Skip to content
Clinical Trials – home
GermanyBack to Germany

Clinical trials in Torgau

9 clinical trials in Torgau, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.

GermanyOur site in GermanyKlinischeStudien.de(opens in a new tab)
Torgau at a glance
9
clinical trials
  • Not yet recruiting0
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

9 trials in Torgau

Open in trial search
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Letrozole
  • Sponsor:Olema Pharmaceuticals Inc.
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Camizestrant
  • Sponsor:GBG Forschungs GmbH
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Anastrozole
  • Sponsor:Institut fuer Frauengesundheit GmbH
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Anastrozole
  • Sponsor:AstraZeneca AB
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Abemaciclib
  • Sponsor:AstraZeneca AB
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:GBG Forschungs GmbH
Countries:GermanyGermany
  • Participants:65+ years
  • Substances:Anastrozole
  • Sponsor:European Organisation For Research And Treatment Of Cancer

Neoplasm malignant

Not recruiting
Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Atezolizumab
  • Sponsor:NSABP Foundation Inc.
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Hydroxycarbamide
  • Sponsor:Novartis Pharma GmbH

Other cities in Germany

The busiest research cities in the country

All 515 cities in Germany

Clinical research in Torgau

What the registry says about research in the country

01 Breast Cancer Research

Groundbreaking clinical trials focusing on triple-negative breast cancer and HER2-negative breast cancer treatments, investigating innovative therapeutic approaches combining immunotherapy with standard treatments.

  • Triple-negative breast cancer therapies
  • Early-stage breast cancer treatments
  • Neoadjuvant chemotherapy studies

Advanced research exploring personalized treatment options for various breast cancer subtypes.

02 Hormone Receptor Studies

Investigating novel treatments for ER+/HER2- breast cancer, with particular focus on extended endocrine therapy and new therapeutic agents to prevent cancer recurrence.

  • Extended adjuvant therapy
  • Hormone receptor-positive treatments
  • Disease recurrence prevention

Comprehensive evaluation of hormone-targeted therapies in early and advanced stages.

03 Hematological Research

Innovative studies on polycythemia vera utilizing artificial intelligence to predict treatment resistance and optimize patient care pathways.

  • Hydroxyurea resistance evaluation
  • AI-driven prediction models
  • Blood disorder management

Integration of machine learning technologies with clinical practice to enhance treatment outcomes.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.